CLICK THERAPEUTICS
Click Therapeutics develops and commercializes software as medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click�... ��s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.
CLICK THERAPEUTICS
Industry:
Biotechnology Health Care Medical Device Pharmaceutical Therapeutics
Founded:
2012-04-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.clicktherapeutics.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
926.38 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Font Awesome Global Site Tag Euro Apple Mobile Web App Capable
Similar Organizations
Icosavax
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.
VYNE Therapeutics
VYNE Therapeutics is a clinical late-stage biopharmaceutical company developing treatments associated with dermatologic conditions.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2012-08-06 | ProGevity Neuroscience | ProGevity Neuroscience acquired by Click Therapeutics | N/A |
Investors List
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Click Therapeutics
Hikma Ventures
Hikma Ventures investment in Series B - Click Therapeutics
Revelation Partners
Revelation Partners investment in Series B - Click Therapeutics
Ridgetop Health
Ridgetop Health investment in Series B - Click Therapeutics
H.I.G. BioHealth Partners
H.I.G. BioHealth Partners investment in Series B - Click Therapeutics
Sanofi Ventures
Sanofi Ventures investment in Series B - Click Therapeutics
Health Catalyst Capital
Health Catalyst Capital investment in Series B - Click Therapeutics
K2 HealthVentures
K2 HealthVentures investment in Series B - Click Therapeutics
Accelmed
Accelmed investment in Series B - Click Therapeutics
K2 HealthVentures
K2 HealthVentures investment in Debt Financing - Click Therapeutics
Official Site Inspections
http://www.clicktherapeutics.com Semrush global rank: 3.6 M Semrush visits lastest month: 3.98 K
- Host name: server-52-85-132-42.iad50.r.cloudfront.net
- IP address: 52.85.132.42
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Click Therapeutics"
About Us | Our Team | Click Therapeutics
We are a passionate and diverse cross-functional team of engineers, designers, data scientists, product managers, clinicians, scientists, privacy and regulatory experts.See details»
Click Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Click Therapeutics develops and commercializes software as medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital …See details»
Click Therapeutics and Boehringer Ingelheim Announce FDA …
NEW YORK – January 4, 2024 – Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that the investigational …See details»
Click Therapeutics, Inc. | LinkedIn
Click Therapeutics, Inc. | 18,491 followers on LinkedIn. Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments ...See details»
Click Therapeutics - Digital Therapeutics Alliance
Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for patients with unmet medical needs. Through cognitive and neurobehavioral mechanisms, …See details»
Partnership-with-clicktherapeutics | Boehringer Ingelheim
Sep 11, 2020 For more information, visit ClickTherapeutics.com. Media Contacts Linda Ruckel Senior Associate Director, Media and Corporate Reputation Boehringer Ingelheim U.S. Media …See details»
BI & Click Therapeutics Enter Partnership | BI US - Boehringer …
Ingelheim, Germany and New York, New York, 11 September 2020 – Boehringer Ingelheim and Click Therapeutics today announced they have entered into a collaboration for the …See details»
Click Therapeutics - Overview, News & Similar companies
Click Therapeutics contact info: Phone number: (646) 248-7933 Website: www.clicktherapeutics.com What does Click Therapeutics do? Founded in 2012, Click …See details»
Click Therapeutics Receives FDA Breakthrough Device Designation …
NEW YORK – December 16, 2022 – Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that it has received …See details»
Click Therapeutics Completes $52 Million Series B ... - Business Wire
Oct 22, 2021 Daniel Busby VP, Investor Relations & Strategic Finance [email protected]. Media Contact. Karen Sharma [email protected] …See details»
Click Therapeutics Expands its Leadership with Executive and …
Apr 7, 2021 Click Therapeutics, Inc. Kyle Amelung, PharmD Director, Strategic Development [email protected] Media Contact MacDougall Karen Sharma …See details»
Click Therapeutics Expands its Leadership with Executive and …
Apr 7, 2021 NEW YORK--Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced three corporate governance additions to …See details»
Click Therapeutics and Boehringer Ingelheim Announce FDA …
NEW YORK, January 04, 2024--Click Therapeutics and Boehringer Ingelheim Announce FDA Breakthrough Device Designation for PDT to Treat Negative Symptoms of SchizophreniaSee details»
Click Therapeutics and Boehringer Ingelheim Announce FDA …
Jan 4, 2024 For more information, visit www.clicktherapeutics.com and connect with us on LinkedIn. About Boehringer Ingelheim Boehringer Ingelheim is working on breakthrough …See details»
Click Therapeutics Announces Collaboration with Indivior to …
Sep 7, 2023 For more information, visit www.clicktherapeutics.com and connect with us on LinkedIn. Contacts. Investor Daniel Busby [email protected]. Media Jonni Mills …See details»
Otsuka and Click Therapeutics Initiate First-of-its-Kind Fully …
Feb 24, 2021 According to the World Health Organization, depression is a leading cause of disability worldwide, and is a major contributor to the overall global burden of disease. 2 Click …See details»
Our Clinical Trials - Click Therapeutics
Clinical trials are carefully designed research studies that evaluate safety, efficacy and effectiveness of new treatments or interventions. The process involves screening for eligibility, …See details»
Otsuka and Click Therapeutics Initiate First-of-its-Kind Fully …
Feb 24, 2021 According to the World Health Organization, depression is a leading cause of disability worldwide, and is a major contributor to the overall global burden of disease. 2 Click …See details»
Click Therapeutics Launches Additional Randomized Clinical Study …
Aug 2, 2023 [email protected]. Media Contact. Jonni Mills [email protected]. References. 1. Stovner, L. J. & GBD 2016 Headache Collaborators. (2018). Global, regional, …See details»